Ads
related to: what is anxiolytics drugsfreshdiscover.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Barbiturates are powerful anxiolytics but the risk of abuse and addiction is high. Many experts consider these drugs obsolete for treating anxiety but valuable for the short-term treatment of severe insomnia, though only after benzodiazepines or non-benzodiazepines have failed. [29]
An anxiotropic (/ˌæŋksiəˈtɹoʊpɪk/) agent is one that modifies anxiety, a human emotion that has homologous processes in animals. In psychopharmacology anxiotropic agents consist of two categories of psychoactive drugs: anxiolytics that reduce anxiety and may be used therapeutically, and anxiogenic compounds that increase anxiety.
These medications go by a few names — they’re sometimes called anxiolytics, or anti-anxiety drugs. Anxiety medications may even fall under other medication categories, like antidepressants ...
Barbituric acid, the parent structure of all barbiturates. Barbiturates [a] are a class of depressant drugs that are chemically derived from barbituric acid. [2] They are effective when used medically as anxiolytics, hypnotics, and anticonvulsants, but have physical and psychological addiction potential as well as overdose potential among other possible adverse effects.
Nonbenzodiazepine drugs are much more selective than the older benzodiazepine anxiolytics, producing effective relief of anxiety/panic with little or no sedation, anterograde amnesia, or anticonvulsant effects, and are thus potentially more precise than older, anti-anxiety drugs.
Vyvanse (lisdexamfetamine) – a pro-drug stimulant used to treat attention deficit hyperactivity disorder and binge eating disorder; Vyvanse is converted into Dexedrine in vivo; Viibryd – an antidepressant of the serotonin modulator and stimulators class; Vivactil (protriptyline) an antidepressant also used in the treatment of nerve pain
Ads
related to: what is anxiolytics drugsfreshdiscover.com has been visited by 100K+ users in the past month